Background: Loop duodenojejunal bypass with sleeve gastrectomy (LDJB-SG) is a simplified biliopancreatic diversion with duodenal switch.
Objectives: This study investigated the therapeutic outcomes of LDJB-SG and predictors of type 2 diabetes (T2D) remission in Chinese patients with a body mass index (BMI) of 20 to 32.5 kg/m2.
Setting: A university hospital.
Methods: This retrospective study included 28 T2D patients with a BMI of 20 to 32.5 kg/m2 who underwent LDJB-SG. T2DM remission, weight loss, postoperative nutrition status, and complications at 1- and 3-year follow-up were assessed. Remission of T2DM was defined as a fasting blood glucose <7 mmol/L and HbA1C <6.5% for 1 year without pharmacological intervention.
Results: At 1-year follow-up after LDJB-SG, the T2D remission rate was 75% (21/28), and the mean total weight loss was 23.6%. The 3-year T2D remission rate and percent of total weight loss were 68.4% (13/19) and 20.3%, respectively. Univariate and multivariate analysis indicated that duration of T2D was the only risk factor associated with T2D remission (P < .05). LDJB-SG improved the metabolic syndrome by increasing the high-density lipoprotein cholesterol level (P = .0157), decreasing waist circumference (P < .0001), and decreasing triglycerides (P = .0053). Postoperative complications of LDJB-SG included malodorous flatus (64.3%), accidental diarrhea induced by greasy food (57.1%), de novo gastroesophageal reflux disease (28.6%), anemia (25%), fatigue (21.4%), underweight (17.9%), intolerance to cooked rice (10.7%), constipation (7.1%), and steatorrhea (3.6%).
Conclusion: LDJB-SG resulted in acceptable T2D remission and metabolic improvement at 1- and 3-year follow-up in Chinese T2D patients with a BMI of 20 to 32.5 kg/m2. T2D duration may serve as the predictor of T2D remission. LDJB-SG should be performed with caution because of the high incidence of postoperative complications.
Keywords: Complications; Loop duodenojejunal bypass with sleeve gastrectomy; Low BMI; Predictor; Remission; Type 2 diabetes.
Copyright © 2019. Published by Elsevier Inc.
Loop Duodenojejunal Bypass with Sleeve Gastrectomy: Comparative Study with Roux-en-Y Gastric Bypass in Type 2 Diabetic Patients with a BMI <35 kg/m(2), First Year Results.Obes Surg. 2016 Oct;26(10):2291-301. doi: 10.1007/s11695-016-2118-z. Obes Surg. 2016. PMID: 26935711
Laparoscopic loop duodenaljejunal bypass with sleeve gastrectomy in type 2 diabetic patients.Surg Obes Relat Dis. 2019 May;15(5):696-702. doi: 10.1016/j.soard.2019.01.016. Epub 2019 Jan 25. Surg Obes Relat Dis. 2019. PMID: 30935839
Duodenal-jejunal bypass with sleeve gastrectomy versus the sleeve gastrectomy procedure alone: the role of duodenal exclusion.Surg Obes Relat Dis. 2015 Jul-Aug;11(4):765-70. doi: 10.1016/j.soard.2014.12.017. Epub 2014 Dec 24. Surg Obes Relat Dis. 2015. PMID: 25813754
Surgery for weight loss in adults.Cochrane Database Syst Rev. 2014 Aug 8;(8):CD003641. doi: 10.1002/14651858.CD003641.pub4. Cochrane Database Syst Rev. 2014. PMID: 25105982 Review.
Gastric bypass and sleeve gastrectomy for type 2 diabetes: a systematic review and meta-analysis of outcomes.Obes Surg. 2013 Dec;23(12):1994-2003. doi: 10.1007/s11695-013-1030-z. Obes Surg. 2013. PMID: 23955521 Review.